BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 8837328)

  • 1. Neuroendocrine differentiation in non-neuroendocrine thyroid carcinoma.
    Kargi A; Yörükoglu ; Aktaş S; Cakalagaoglu ; Ermete M
    Thyroid; 1996 Jun; 6(3):207-10. PubMed ID: 8837328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine differentiation in follicle-cell thyroid carcinoma: correlation to prognostic factors in papillary carcinoma.
    Tseleni-Balafouta S; Kavantzas N; Alevizaki M; Paraskevakou H; Davaris P
    J Exp Clin Cancer Res; 1998 Dec; 17(4):533-7. PubMed ID: 10089080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid medullary carcinoma with thyroglobulin immunoreactivity in sporadic multiple endocrine neoplasia type 2-B.
    Kovacs CS; Masé RM; Kovacs K; Nguyen GK; Chik CL
    Cancer; 1994 Aug; 74(3):928-32. PubMed ID: 7913660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine differentiation in prostatic carcinomas. A retrospective autopsy study.
    Turbat-Herrera EA; Herrera GA; Gore I; Lott RL; Grizzle WE; Bonnin JM
    Arch Pathol Lab Med; 1988 Nov; 112(11):1100-5. PubMed ID: 2460064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Histopathological and immunohistochemical studies on medullary thyroid carcinoma].
    Jiang C; Tan Y; Li E
    Zhonghua Bing Li Xue Za Zhi; 1996 Dec; 25(6):332-5. PubMed ID: 9388857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine differentiation in colorectal carcinomas.
    Syversen U; Halvorsen T; Mårvik R; Waldum HL
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):667-74. PubMed ID: 8590163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical study of neuroendocrine differentiation in primary glandular lesions and tumors of the urinary bladder.
    Bollito ER; Pacchioni D; Lopez-Beltran A; Volante M; Terrone C; Casetta G; Mari M; DePompa R; Cappia S; Papotti M
    Anal Quant Cytol Histol; 2005 Aug; 27(4):218-24. PubMed ID: 16220833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed medullary-follicular carcinoma of the thyroid gland: a clinicopathologic variant of medullary thyroid carcinoma.
    Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Ishizaki T
    Mod Pathol; 1996 Jun; 9(6):631-5. PubMed ID: 8782199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent expression of neuroendocrine markers in mucinous tubular and spindle cell carcinoma of the kidney.
    Kuroda N; Hes O; Miyazaki E; Shuin T; Enzan H
    Histol Histopathol; 2006 Jan; 21(1):7-10. PubMed ID: 16267782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A poorly differentiated thyroid carcinoma with neuroendocrine traits.
    Boronat M; Isla C; Nóvoa FJ; Cabrera JJ
    Thyroid; 2004 Feb; 14(2):163-4. PubMed ID: 15068633
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuroendocrine marker expression in thyroid epithelial tumors.
    Satoh F; Umemura S; Yasuda M; Osamura RY
    Endocr Pathol; 2001; 12(3):291-9. PubMed ID: 11740050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results after surgery in undifferentiated large cell carcinoma of the lung: the role of neuroendocrine expression.
    Wertzel H; Grahmann PR; Bansbach S; Lange W; Hasse J; Böhm N
    Eur J Cardiothorac Surg; 1997 Nov; 12(5):698-702. PubMed ID: 9458138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine differentiation in 32 cases of so-called sclerosing hemangioma of the lung: identified by immunohistochemical and ultrastructural study.
    Xu HM; Li WH; Hou N; Zhang SG; Li HF; Wang SQ; Yu ZY; Li ZJ; Zeng MY; Zhu GM
    Am J Surg Pathol; 1997 Sep; 21(9):1013-22. PubMed ID: 9298877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of neuroendocrine differentiation in NSCLC and its clinical significance].
    Ouyang N; Chen G; Ding J
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Feb; 24(2):90-2. PubMed ID: 11802946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine differentiation in prostatic intraepithelial neoplasia and adenocarcinoma.
    Bostwick DG; Dousa MK; Crawford BG; Wollan PC
    Am J Surg Pathol; 1994 Dec; 18(12):1240-6. PubMed ID: 7977947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxyphil and squamous variants of medullary thyroid carcinoma.
    Dominguez-Malagon H; Delgado-Chavez R; Torres-Najera M; Gould E; Albores-Saavedra J
    Cancer; 1989 Mar; 63(6):1183-8. PubMed ID: 2917321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemistry of thyroid carcinoma--an experience with thyroglobulin and calcitonin.
    Kavishwar VS; Phatak AM; Rege JD
    Indian J Pathol Microbiol; 1998 Apr; 41(2):163-7. PubMed ID: 9670628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical identification of neuron-specific enolase, synaptophysin, chromogranin and endocrine granule constituent in neuroendocrine tumours.
    Vyberg M; Horn T; Francis D; Askaa J
    Acta Histochem Suppl; 1990; 38():179-81. PubMed ID: 1964227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of pan-neuroendocrine proteins in 53 neuroblastic tumors. An immunohistochemical study with neuron-specific enolase, chromogranin, and synaptophysin.
    Hachitanda Y; Tsuneyoshi M; Enjoji M
    Arch Pathol Lab Med; 1989 Apr; 113(4):381-4. PubMed ID: 2495784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microtubule-associated protein-2: a new sensitive and specific marker for pulmonary carcinoid tumor and small cell carcinoma.
    Liu Y; Sturgis CD; Grzybicki DM; Jasnosz KM; Olson PR; Tong M; Dabbs DD; Raab SS; Silverman JF
    Mod Pathol; 2001 Sep; 14(9):880-5. PubMed ID: 11557784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.